ISA Pharmaceuticals Overview

  • Founded
  • 2004
Founded
  • Status
  • Private
  • Employees
  • 36
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $31.1M
Latest Deal Amount
  • Investors
  • 3

ISA Pharmaceuticals General Information

Description

Developer of synthetic therapeutic vaccines designed to provide treatment for cancer. The company's vaccines are based on proprietary synthetic long peptide technologies that provide treatment for cancer and persistent viral infections, providing patients with treatment having a better likelihood of success.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • Leiden Bio Science Park
  • De Limes 7, Oegstgeest
  • 2333 DH Leiden
  • Netherlands
+31 085 000 0000

ISA Pharmaceuticals Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ISA Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 06-Jul-2021 $31.1M 000.00 Completed Clinical Trials - Phase 2
6. Later Stage VC 17-Jun-2020 000.00 Completed Clinical Trials - Phase 2
5. Debt - General 13-Oct-2019 0000 000.00 Completed Clinical Trials - General
4. Secondary Transaction - Private 000.00 Completed Clinical Trials - General
3. Later Stage VC 07-Jan-2013 000.00 000.00 Completed Clinical Trials - General
2. Grant $27.3M $14.8M Completed Startup
1. Early Stage VC (Series A) 01-Jan-2004 $14.8M $14.8M Completed Startup
To view ISA Pharmaceuticals’s complete valuation and funding history, request access »

ISA Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of synthetic therapeutic vaccines designed to provide treatment for cancer. The company's vaccines are based o
Drug Discovery
Leiden, Netherlands
36 As of 2021
000.00
0000000000 0 000.00

00000000

nim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
0000000000000
Oxford, United Kingdom
00 As of 0000
000.00
000000000 000.00

000000

tion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
0000 000000000
Liege, Belgium
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ISA Pharmaceuticals Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Scancell Holdings Formerly VC-backed Oxford, United Kingdom 00 000.00 000000000 000.00
000000 Venture Capital-Backed Liege, Belgium 00 000.00 00000000000 000.00
000000000 00000000 Venture Capital-Backed Schlieren, Switzerland 0 000.00 00000000000 000.00
0-0000 00000000000 Formerly VC-backed Cambridge, United Kingdom 00 000.00 000000000000 000.00
000000000 00000000 Venture Capital-Backed Cambridge, United Kingdom 00 00000 0000000000 0 00000
You’re viewing 5 of 8 competitors. Get the full list »

ISA Pharmaceuticals Executive Team (10)

Name Title Board Seat Contact Info
Gerben Moolhuizen Chief Executive Officer
Willem-Jan Krebber Chief Operating Officer
Kees Melief Ph.D Co-Founder & Chief Scientific Officer
Leon Hooftman MD Chief Medical Officer
You’re viewing 4 of 10 executive team members. Get the full list »

ISA Pharmaceuticals Board Members (7)

Name Representing Role Since
Bart Bergstein Self Chairman 000 0000
Hendrik Zonnenberg Self Board Member 000 0000
Markwin Velders Ph.D ISA Pharmaceuticals Board Member 000 0000
Pieter van der Meijden Self Board Member 000 0000
You’re viewing 4 of 7 board members. Get the full list »

ISA Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ISA Pharmaceuticals Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Invest-NL (Investment Company) Impact Investing Minority 000 0000 000000 0
Regeneron Pharmaceuticals Corporation Minority 000 0000 000000 0
De Hoge Dennen Capital Family Office Minority 000 0000 000000 0
To view ISA Pharmaceuticals’s complete investors history, request access »